Award
National Institute on Minority Health and Health Disparities 5U54MD007602-39
A multiomic analysis of HER2/ERBB2 in African American men with prostate cancer
Recipient
Morehouse School of Medicine
Award Amount
$314,706.00
Ceiling
$314,706.00
Awarded
July 28, 2026
Identifier
5U54MD007602-39
Award for research on HER2 overexpression in African American men with prostate cancer, focusing on molecular mechanisms, treatment resistance, and outcome disparities using multiomic analyses.
Description
This project investigates HER2 overexpression in African American prostate cancer patients, its correlation with West African ancestry, and its impact on tumor biology, treatment response, and survival outcomes. The research involves multiomic analyses to identify signatures predictive of treatment resistance and aims to inform precision medicine trials to reduce disparities in prostate cancer outcomes among African American men.